The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I results from a phase 1/2 multi-center study of nab-sirolimus combined with mFOLFOX6+bevacizumab (FB) as first-line (1L) therapy in patients (pts) with metastatic colorectal cancer (mCRC) with or without PTEN loss.
 
Sunil Sharma
Stock and Other Ownership Interests - Bauerfeind; Beta Cat Pharmaceuticals; ConverGene; Elevar Therapeutics; HLB; Proteus Digital Health; Salarius Pharmaceuticals; Stingray Therapeutics
Honoraria - Array BioPharma; Bauerfeind; Dracen; Exelixis; Exelixis; Hengrui Therapeutics; Loxo; Tarveda Therapeutics
Consulting or Advisory Role - Bauerfeind; Dracen
Research Funding - AADi; Celgene; City of Hope; City of Hope; Hengrui Therapeutics; Honor Health; Honor Health; Inhibrx; Merck; Novartis; OncoMed; Plexxikon; Syndax; Tesaro; Toray Industries
Patents, Royalties, Other Intellectual Property - International PCT Application No. PCT/US20/13618 Title: BISPHOSPHONATE CONJUGATES AND USES THEREOF; Provisional Application No. 62/961,930. Title: PepSeq as a platform to identify synthetic molecular binding agents; Provisional application number: 62/818,037 Title: Trisubstituted Pyrazolo [1, 5-a] Pyrimidine Compounds and Methods of Use Thereof
Travel, Accommodations, Expenses - Bauerfeind; Dracen; Exelixis; Hengrui Therapeutics; Loxo; Tarveda Therapeutics
 
E. Gabriela Chiorean
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Celgene; Eisai; Five Prime Therapeutics; Halozyme; Ipsen; Legend Biotech; Seagen; Vicus Therapeutics
Research Funding - AADi (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); FibroGen; Halozyme (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); MacroGenics (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Legend Biotech; Seagen
 
Angela Tatiana Alistar
Consulting or Advisory Role - Rafael Pharmaceuticals
Speakers' Bureau - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Rafael Pharmaceuticals
 
Fadi S. Braiteh
Honoraria - Abbott Nutrition; Amgen; ARIAD; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech/Roche; HERON; Immunomedics; Incyte; Insys Therapeutics; Ipsen; Lexicon; Lilly; Puma Biotechnology; Taiho Pharmaceutical
Consulting or Advisory Role - Ambry Genetics; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Ipsen; Lexicon; Lilly; Merck; Merrimack; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Marc Ryan Matrana
Consulting or Advisory Role - Strata Oncology
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; Merck
 
Carlos Roberto Becerra
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Bayer; HERON; Ipsen; SOBI; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Taiho Pharmaceutical
 
Berta Grigorian
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Shihe Hou
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Anita N. Schmid
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Neil Desai
Employment - AADi
Leadership - AADi
Stock and Other Ownership Interests - AADi